Phenylephrine tannate, often combined with chlorpheniramine tannate, is designed to relieve upper respiratory symptoms by leveraging both decongestant and antihistamine effects. The tannate salt provides extended-release benefits, enabling dosing every 8–12 hours, though absorption remains comparable to other forms. It is grouped under the following drug class(es): Vasoconstrictors. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Rynatan and Metaoxedrine. Its PubChem CID is 165411843.
Phenylephrine tannate
| CAS No | 1416-03-1 |
|---|---|
| Molecular Formula | C85H65NO48 |
| Molecular Weight | 1868.4 g/mol |
| Synonyms | [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate;3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Phenylephrine tannate, often combined with chlorpheniramine tannate, is designed to relieve upper respiratory symptoms by leveraging both decongestant and antihistamine effects.
The listed CAS number is 1416-03-1.
The listed molecular formula is C85H65NO48.
The listed molecular weight is 1868.4 g/mol.
[2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate;3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol.
The source lists Rynatan and Metaoxedrine.